世界卫生组织烟草控制学习框架公约。

IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Health Security Pub Date : 2023-09-01 Epub Date: 2023-08-08 DOI:10.1089/hs.2023.0094
Joanna E Cohen, Matthew L Myers, Indu B Ahluwalia
{"title":"世界卫生组织烟草控制学习框架公约。","authors":"Joanna E Cohen, Matthew L Myers, Indu B Ahluwalia","doi":"10.1089/hs.2023.0094","DOIUrl":null,"url":null,"abstract":"We are pleased that the World Health Organization (WHO) is developing a pandemic treaty to improve the global response to future pandemics. In their article, De Luca and Ramirez rightly argue that a pandemic treaty should be informed by experiences with WHO’s existing treaty, the WHO Framework Convention on Tobacco Control (WHO FCTC), which came into force in 2005. However, the authors have mischaracterized the WHO FCTC and made criticisms that could hinder a productive discussion about a treaty for pandemics. The authors identify a limited emphasis on ‘‘harm reduction’’ as a key limitation of the WHO FCTC. However, the treaty itself includes ‘‘harm reduction strategies’’ in its definition of tobacco control. As the authors indicate, harm reduction encompasses actions ‘‘aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely or permanently.’’ The WHO FCTC and its guidelines for implementation—which include requiring smoke-free public places; banning tobacco advertising, promotion, and sponsorship; and reducing the attractiveness of tobacco products by limiting flavoring agents—allow the continuation of product use, while reducing the negative effects. Further, the treaty applies to all tobacco products, including products beyond cigarettes. The Conference of the Parties to the WHO FCTC, the governing body of the Convention, has outlined measures that Parties should prioritize to address the challenge of tobacco products, such as heated tobacco products, as well as policy objectives and options for Parties to consider in regulating electronic nicotine delivery systems and electronic non-nicotine delivery systems. It is also crucial to point out that the relationship between the tobacco industry and tobacco-caused death and disease is very different than the relationship of pharmaceutical and other companies to an infectious disease pandemic. The tobacco industry’s own products are responsible for the deaths and diseases the treaty addresses. This is not the case with a pandemic caused by an infectious agent. Tobacco companies are driven to sell their products and find new users, which is a fundamental and irreconcilable conflict","PeriodicalId":12955,"journal":{"name":"Health Security","volume":" ","pages":"428-429"},"PeriodicalIF":2.1000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541915/pdf/","citationCount":"0","resultStr":"{\"title\":\"WHO Framework Convention on Tobacco Control Learnings.\",\"authors\":\"Joanna E Cohen, Matthew L Myers, Indu B Ahluwalia\",\"doi\":\"10.1089/hs.2023.0094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We are pleased that the World Health Organization (WHO) is developing a pandemic treaty to improve the global response to future pandemics. In their article, De Luca and Ramirez rightly argue that a pandemic treaty should be informed by experiences with WHO’s existing treaty, the WHO Framework Convention on Tobacco Control (WHO FCTC), which came into force in 2005. However, the authors have mischaracterized the WHO FCTC and made criticisms that could hinder a productive discussion about a treaty for pandemics. The authors identify a limited emphasis on ‘‘harm reduction’’ as a key limitation of the WHO FCTC. However, the treaty itself includes ‘‘harm reduction strategies’’ in its definition of tobacco control. As the authors indicate, harm reduction encompasses actions ‘‘aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely or permanently.’’ The WHO FCTC and its guidelines for implementation—which include requiring smoke-free public places; banning tobacco advertising, promotion, and sponsorship; and reducing the attractiveness of tobacco products by limiting flavoring agents—allow the continuation of product use, while reducing the negative effects. Further, the treaty applies to all tobacco products, including products beyond cigarettes. The Conference of the Parties to the WHO FCTC, the governing body of the Convention, has outlined measures that Parties should prioritize to address the challenge of tobacco products, such as heated tobacco products, as well as policy objectives and options for Parties to consider in regulating electronic nicotine delivery systems and electronic non-nicotine delivery systems. It is also crucial to point out that the relationship between the tobacco industry and tobacco-caused death and disease is very different than the relationship of pharmaceutical and other companies to an infectious disease pandemic. The tobacco industry’s own products are responsible for the deaths and diseases the treaty addresses. This is not the case with a pandemic caused by an infectious agent. Tobacco companies are driven to sell their products and find new users, which is a fundamental and irreconcilable conflict\",\"PeriodicalId\":12955,\"journal\":{\"name\":\"Health Security\",\"volume\":\" \",\"pages\":\"428-429\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541915/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Security\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/hs.2023.0094\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/8/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Security","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/hs.2023.0094","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
WHO Framework Convention on Tobacco Control Learnings.
We are pleased that the World Health Organization (WHO) is developing a pandemic treaty to improve the global response to future pandemics. In their article, De Luca and Ramirez rightly argue that a pandemic treaty should be informed by experiences with WHO’s existing treaty, the WHO Framework Convention on Tobacco Control (WHO FCTC), which came into force in 2005. However, the authors have mischaracterized the WHO FCTC and made criticisms that could hinder a productive discussion about a treaty for pandemics. The authors identify a limited emphasis on ‘‘harm reduction’’ as a key limitation of the WHO FCTC. However, the treaty itself includes ‘‘harm reduction strategies’’ in its definition of tobacco control. As the authors indicate, harm reduction encompasses actions ‘‘aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely or permanently.’’ The WHO FCTC and its guidelines for implementation—which include requiring smoke-free public places; banning tobacco advertising, promotion, and sponsorship; and reducing the attractiveness of tobacco products by limiting flavoring agents—allow the continuation of product use, while reducing the negative effects. Further, the treaty applies to all tobacco products, including products beyond cigarettes. The Conference of the Parties to the WHO FCTC, the governing body of the Convention, has outlined measures that Parties should prioritize to address the challenge of tobacco products, such as heated tobacco products, as well as policy objectives and options for Parties to consider in regulating electronic nicotine delivery systems and electronic non-nicotine delivery systems. It is also crucial to point out that the relationship between the tobacco industry and tobacco-caused death and disease is very different than the relationship of pharmaceutical and other companies to an infectious disease pandemic. The tobacco industry’s own products are responsible for the deaths and diseases the treaty addresses. This is not the case with a pandemic caused by an infectious agent. Tobacco companies are driven to sell their products and find new users, which is a fundamental and irreconcilable conflict
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Security
Health Security PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
4.80
自引率
6.10%
发文量
70
期刊介绍: Health Security is a peer-reviewed journal providing research and essential guidance for the protection of people’s health before and after epidemics or disasters and for ensuring that communities are resilient to major challenges. The Journal explores the issues posed by disease outbreaks and epidemics; natural disasters; biological, chemical, and nuclear accidents or deliberate threats; foodborne outbreaks; and other health emergencies. It offers important insight into how to develop the systems needed to meet these challenges. Taking an interdisciplinary approach, Health Security covers research, innovations, methods, challenges, and ethical and legal dilemmas facing scientific, military, and health organizations. The Journal is a key resource for practitioners in these fields, policymakers, scientific experts, and government officials.
期刊最新文献
Enhancing Special Pathogen Preparedness Through Exercises: Navigating Dual Quarantine Activations. How the IHR (2005) Shaped the COVID-19 Pandemic Response in the Eastern Mediterranean Region: What Went Well and What Did Not. Metagenomic Sequencing for Early Detection of Future Engineered Pandemics: Foreshadowing the Privacy Challenge. Global High-Consequence Infectious Disease Readiness and Response: An Inventory of High-Level Isolation Units. A Century of Assessment: The Collection of Biothreat Risk Assessments (COBRA).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1